Invizyne Technologies, Inc. (IZTC)

Market Cap	108.18M
Revenue (ttm)	-700
Net Income (ttm)	-5.12M
Shares Out	8.13M
EPS (ttm)	-0.82
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,208
Open	10.80
Previous Close	12.27
Day's Range	10.80 - 13.31
52-Week Range	8.50 - 19.37
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About IZTC

Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.

• Industry: Specialty Chemicals
• Sector: Materials
• IPO Date: Nov 13, 2024
• Employees: 29
• Stock Exchange: NASDAQ
• Ticker Symbol: IZTC
• Website: https://www.invizyne.com

Financial Performance

In 2023, Invizyne Technologies's revenue was $70,069, an increase of 145.01% compared to the previous year's $28,598. Losses were -$2.04 million, 46.0% more than in 2022.